Tower Research Capital LLC (TRC) - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2024$178,552
+1696.7%
20,062
+1945.1%
0.00%
Q1 2024$9,938
-93.6%
981
-93.7%
0.00%
-100.0%
Q4 2023$156,423
+290.9%
15,549
+264.1%
0.00%
+100.0%
Q3 2023$40,020
-71.7%
4,271
-26.0%
0.00%
-80.0%
Q2 2023$141,636
+164593.0%
5,774
+56.0%
0.01%
+66.7%
Q1 2023$86
-48.5%
3,701
-43.9%
0.00%
-57.1%
Q4 2022$167
-99.9%
6,593
-1.6%
0.01%
+250.0%
Q3 2022$129,000
-81.0%
6,697
-74.9%
0.00%
-86.7%
Q2 2022$680,000
+50.1%
26,672
+51.3%
0.02%
+275.0%
Q1 2022$453,000
-31.8%
17,624
+11.1%
0.00%
-63.6%
Q4 2021$664,000
+544.7%
15,861
+573.8%
0.01%
+266.7%
Q3 2021$103,000
-49.0%
2,354
-45.1%
0.00%
-40.0%
Q2 2021$202,000
+68.3%
4,285
+83.2%
0.01%
+150.0%
Q1 2021$120,000
+224.3%
2,339
+69.7%
0.00%
+100.0%
Q4 2020$37,000
-97.6%
1,378
-96.9%
0.00%
-94.1%
Q3 2020$1,546,000
+923.8%
45,042
+1120.3%
0.02%
+183.3%
Q2 2020$151,000
+529.2%
3,691
+93.4%
0.01%
+200.0%
Q4 2019$24,0001,9080.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$39,700,00030.52%
SB INVESTMENT ADVISERS (UK) LTD 22,216,644$565,858,0004.50%
Zebra Capital Management LLC 25,419$647,0001.90%
Alaska Permanent Fund Corp 2,300,000$58,581,0000.84%
CLARK ESTATES INC/NY 180,000$4,585,0000.79%
Temasek Holdings (Private) Ltd 5,602,553$142,697,0250.78%
SECTOR GAMMA AS 110,223$2,807,0000.63%
Avidity Partners Management LP 758,211$19,312,0000.44%
New Vernon Capital Holdings II LLC 14,501$369,0000.30%
DUALITY ADVISERS, LP 116,415$2,965,0000.29%
View complete list of VIR BIOTECHNOLOGY INC shareholders